Blumberg Capital shares the latest Cybersecurity news, insights, videos and events from our firm and our Cybersecurity portfolio companies.
With $30 million in a Series B round, Medigate is aiming to not only expand its security offering but also offer detailed analytics to help hospitals make better decisions about medical device usage to help control costs.
Blumberg Capital is an early-stage venture capital firm that partners with passionate entrepreneurs to innovate and build successful technology companies.
© Blumberg Capital. All rights reserved. 432 Bryant St. San Francisco, CA 94107